IMNM Research Grant supports researchers studying immune-mediated necrotizing myopathy to advance understanding of the disease, develop or improve treatments, and enhance patients' quality of life.
Applications for the 2026 IMNM Research Grant are now closed. TMA asks applicants to check back in Spring 2027.
IBM/IMNM Fellowship supports mentored clinical and research trainees studying inclusion body myositis and immune-mediated necrotizing myopathy to advance understanding, treatment, and quality of life.
A Foundation Building Strength funds innovative research to advance scientific understanding and treatment of Nemaline Myopathy through its Nemaline Myopathy Research Grants.
Cure IBM Research Fund at TMA supports researchers studying early muscle-fiber changes and disease mechanisms to advance understanding of inclusion body myositis causes, inflammation, and degeneration.
Neuromuscular Research Grants support mid-career and established investigators pursuing innovative muscle and nerve disorder research to achieve breakthroughs or develop new research techniques and applications.
Biomarker Research Grant: Diagnostic and Prognostic Biomarker Development for Myasthenia Gravis and Related Neuromuscular Junction Disorders funds researchers developing biomarkers to improve diagnosis and prognosis.